XML 50 R38.htm IDEA: XBRL DOCUMENT v3.22.0.1
STOCK-BASED COMPENSATION PLAN (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Arrangement, Option, Activity
Stock option and RSU activity, prices, and values adjusted by the Per Share Consideration, during the year ended December 31, 2021 is as follows (in thousands, except for share, per share, and contractual term data):
Options OutstandingRestricted Stock Units
Number of
shares
Weighted
average
exercise price
Weighted
average
remaining
 contractual
term
(years)
Aggregate
intrinsic
values
($'000s)
Number of plan shares outstandingWeighted average
grant date fair value
per Share
Balances as of December 31, 2019
2,104,223 $0.37 7.82$821 
Recapitalization Impact995,215 (0.12)
Balances at December 31, 2019
3,099,438 $0.25 7.82821 
Granted3,271,856 0.33 
Exercised(108,999)0.06 
Forfeited(529,873)0.29 
Balances as of December 31, 2020
5,732,422 $0.30 8.234,333 
Granted1,454,549 1.75 3,392,153 $10.69 
Exercised(2,496,070)0.27 
Forfeited(894,371)0.46 
Balances as of December 31, 2021
3,796,530 $0.83 8.0840,274 3,392,153 10.69 
Options vested and exercisable - December 31, 2020
2,825,238 $0.26 7.212,215 
Options vested and exercisable - December 31, 2021
1,827,374 $0.31 7.2020,337 
Schedule of Share-based Payment Arrangement, Restricted Stock Unit, Activity
Stock option and RSU activity, prices, and values adjusted by the Per Share Consideration, during the year ended December 31, 2021 is as follows (in thousands, except for share, per share, and contractual term data):
Options OutstandingRestricted Stock Units
Number of
shares
Weighted
average
exercise price
Weighted
average
remaining
 contractual
term
(years)
Aggregate
intrinsic
values
($'000s)
Number of plan shares outstandingWeighted average
grant date fair value
per Share
Balances as of December 31, 2019
2,104,223 $0.37 7.82$821 
Recapitalization Impact995,215 (0.12)
Balances at December 31, 2019
3,099,438 $0.25 7.82821 
Granted3,271,856 0.33 
Exercised(108,999)0.06 
Forfeited(529,873)0.29 
Balances as of December 31, 2020
5,732,422 $0.30 8.234,333 
Granted1,454,549 1.75 3,392,153 $10.69 
Exercised(2,496,070)0.27 
Forfeited(894,371)0.46 
Balances as of December 31, 2021
3,796,530 $0.83 8.0840,274 3,392,153 10.69 
Options vested and exercisable - December 31, 2020
2,825,238 $0.26 7.212,215 
Options vested and exercisable - December 31, 2021
1,827,374 $0.31 7.2020,337 
Schedule of Valuation Assumptions
In accordance with ASC 718, the fair value of each option grant has been estimated as of the date of grant using the following weighted average assumptions:
20212020
Risk-free rate1.01 %0.93 %
Expected dividends— — 
Expected term6 years6 years
Expected volatility75.14 %71.06 %
Schedule of Stock-Based Compensation The following table presents the amount of stock-based compensation related to stock-based awards to employees
on the Company’s consolidated statements of operations and comprehensive loss during the years ended December 31, 2021 and 2020 (in thousands):
20212020
Research and development$2,233 $79 
Sales and marketing213 47 
General and administrative5,476 184 
Total stock-based compensation$7,922 $310